| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 23.51M | 17.81M | 33.57M | -69.03M | 37.18M |
| Gross Profit | 19.17M | 9.96M | 22.75M | -81.38M | 37.18M |
| EBITDA | -9.49M | 5.88M | 17.24M | -85.55M | 26.60M |
| Net Income | -18.73M | 5.88M | 17.24M | -85.55M | 39.58M |
Balance Sheet | |||||
| Total Assets | 306.74M | 299.73M | 277.67M | 327.99M | 433.51M |
| Cash, Cash Equivalents and Short-Term Investments | 51.93M | 34.93M | 5.74M | 9.02M | 9.02M |
| Total Debt | 157.58M | 123.60M | 122.98M | 186.32M | 185.38M |
| Total Liabilities | 161.33M | 139.07M | 126.36M | 189.32M | 188.91M |
| Stockholders Equity | 145.40M | 160.67M | 151.31M | 138.67M | 244.60M |
Cash Flow | |||||
| Free Cash Flow | 18.34M | 25.71M | 26.72M | 19.62M | 16.69M |
| Operating Cash Flow | 18.34M | 25.71M | 26.72M | 19.62M | 16.69M |
| Investing Cash Flow | -32.07M | 0.00 | 38.97M | 752.49K | -124.12M |
| Financing Cash Flow | 30.75M | 3.48M | -68.97M | -20.37M | 57.31M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
63 Neutral | $162.53M | 11.23 | 5.30% | 21.24% | -55.82% | -4.97% | |
59 Neutral | $103.57M | 12.10 | 6.46% | 14.03% | -34.92% | -132.22% | |
57 Neutral | $92.53M | 11.33 | 5.90% | 16.60% | -5.23% | 193.87% | |
56 Neutral | $41.94M | -1.93 | -27.67% | 25.87% | -14.76% | ― | |
49 Neutral | $69.43M | -2.74 | -24.20% | 22.43% | 47.01% | -179.46% | |
46 Neutral | $150.52M | -7.18 | -12.27% | 24.14% | -177.91% | 55.08% |
Oxford Square Capital reported financial results for the quarter ended December 31, 2025, showing a decline in net asset value per share to $1.69 from $1.95 on September 30, 2025, driven by net unrealized depreciation of about $16.0 million and net realized losses of $2.3 million. Net investment income held steady at $0.07 per share on slightly higher total investment income of $10.4 million, while portfolio yields on debt and CLO equity investments edged down modestly and one preferred equity position, with a fair value of about $5.0 million, moved to non-accrual status.
The board on February 26, 2026 declared monthly common stock distributions of $0.035 per share for April, May and June 2026, signaling a continuation of regular shareholder payouts despite pressure on NAV and accumulated losses. During the fourth quarter of 2025 the company was a net investor, with $18.0 million of purchases versus $7.4 million of repayments and no sales, and it raised approximately $7.9 million in net proceeds through an at-the-market equity offering, increasing shares outstanding to about 86.1 million and modestly bolstering its capital base amid a challenging valuation environment.
The most recent analyst rating on (OXSQ) stock is a Hold with a $2.00 price target. To see the full list of analyst forecasts on Oxford Square Capital stock, see the OXSQ Stock Forecast page.